Neuromodulation for Depression

(TREND Trial)

Overseen By Study Coordinator

Age: 18 - 65

Sex: Any

Trial Phase: Academic

Sponsor: Erika Forbes

Must not be taking: Clozapine, Bupropion, Stimulants, Benzodiazepines

Disqualifiers: Bipolar, Psychosis, Seizures, Pregnancy, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Approved in 1 Jurisdiction This treatment is already approved in other countries

Compensation: Varies

Number of Visits: 10

Duration: 2 weeks

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores a new treatment called theta burst stimulation (TBS), a form of transcranial magnetic stimulation (TMS), to determine its effectiveness in reducing depression symptoms. Participants will undergo short TBS sessions over two weeks, with some also receiving training to boost positive feelings. It is suitable for individuals diagnosed with depression who have no history of bipolar disorder, substance abuse, or neurological issues like epilepsy.

As an unphased trial, this study provides a unique opportunity to contribute to innovative research and potentially benefit from cutting-edge treatment.

Will I have to stop taking my current medications?

Yes, you will need to stop taking certain medications. The trial excludes participants who are currently using Clozapine, Bupropion, prescription stimulants, benzodiazepines, or mood stabilizers.

What prior data suggests that theta burst stimulation is safe for treating depression?

Research has shown that theta burst stimulation (TBS) is generally safe for treating depression. Studies comparing TBS to other treatments indicate that it has similar side effects to those of other common treatments. Another review found that TBS is not only effective but also safe and easy for patients to handle. Therefore, joining a trial with TBS offers a well-tolerated option based on existing research. ^{1 2 3 4 5}

Why are researchers excited about this trial?

Theta Burst Stimulation (TBS) is unique because it offers a potentially quicker and non-invasive alternative for treating depression compared to traditional methods like antidepressant medications and electroconvulsive therapy (ECT). TBS uses brief, high-frequency magnetic pulses to modulate brain activity, potentially leading to faster improvements in mood. Unlike medications that can take weeks to work, TBS might show results in just days, making it an exciting option for researchers and patients seeking rapid relief. This technique also avoids systemic side effects associated with drugs, providing a more targeted approach with fewer overall side effects.

What evidence suggests that theta burst stimulation is effective for depression?

Research has shown that theta burst stimulation (TBS), the treatment used in this trial, can help reduce symptoms of depression. Studies have found that TBS works as well as other brain stimulation methods, such as repetitive transcranial magnetic stimulation (rTMS), in relieving depression and anxiety. Most people tolerate the treatment well, experiencing no serious side effects. Specifically, one study found that the decrease in depression symptoms lasted for 26 weeks, suggesting long-term benefits. This makes TBS a promising option for those seeking relief from depression. ^{1 6 7 8 9}

Who Is on the Research Team?

Erika E Forbes, Ph.D

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for individuals with a current diagnosis of depression according to the DSM-5. Participants should not have used certain drugs like cocaine or MDMA recently, have high-risk suicidality, severe substance use disorders, specific medication usage (Clozapine, Bupropion), daily nicotine use, or a history of seizures and other listed conditions.

Inclusion Criteria

You are currently diagnosed with Depressive Disorder according to DSM-5.

Exclusion Criteria

You have consumed a large amount of alcohol within the past week or within the last 12 hours.

You have a mental health condition called obsessive-compulsive disorder, which you have had at any point in your life.

You have a history of mental illness that included losing touch with reality.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete a baseline assessment before starting treatment

1 day

Treatment

Participants receive 20 theta burst stimulation (TBS) sessions over 2 weeks, with sessions delivered twice/day, 5 days/week

2 weeks

10 visits (in-person)

Post-TBS Assessment

Participants complete an assessment after the TBS treatment sessions

1 day

Follow-up

Participants are monitored for safety and effectiveness after treatment, with a follow-up assessment 4 months later

4 months

What Are the Treatments Tested in This Trial?

Interventions

• Theta Burst Stimulation

Trial Overview

The TREND study is testing theta burst stimulation (TBS) as a treatment for depression. Some participants will also receive positive affect training alongside TBS to see if it helps reduce the severity of depression symptoms more effectively.

How Is the Trial Designed?

Group I: TBS Experimental Treatment 1 Intervention

In this open-label trial, all participants will undergo 2 or 3 continuous TBS (cTBS) sessions per visit over 10 days (weekdays, over 2 weeks; total = 20 or 30 TBS sessions in 10 visits). The total time of each pair of sessions (including pause between sessions) will be approximately 1 hour, with each session lasting approximately 100 seconds. There is only 1 group and 1 arm of the study. All participants will receive the treatment.

Theta Burst Stimulation is already approved in United States for the following indications:

Approved in United States as Theta Burst Stimulation for:

• Major Depressive Disorder

Who Is Running the Clinical Trial?

Erika Forbes

Lead Sponsor

Trials

3

Recruited

180+

Published Research Related to This Trial

In a case series of 9 patients with major depressive disorder and bipolar disorder, accelerated theta-burst rTMS treatment over 8 days led to significant reductions in depression symptoms, as measured by the CES-D and CGI scales.

The treatment was well tolerated, with mild headaches being the most common side effect, and five patients achieving at least a 50% reduction in symptoms by the end of the treatment period.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Accelerated theta-burst repetitive transcranial magnetic stimulation for depression in South Africa. Bröcker, E., van den Heuvel, L., Seedat, S.[2020]

In a randomized-controlled trial involving 32 patients with major depression, bilateral theta burst stimulation (TBS) to the dorsolateral prefrontal cortex showed a significant increase in treatment response compared to sham stimulation, with 9 responders in the TBS group versus 4 in the sham group.

The study also indicated a trend towards higher remission rates in the TBS group as measured by the Beck Depression Inventory, suggesting that TBS may enhance the effectiveness of ongoing medication and psychotherapy in treating major depression.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Treatment of major depression with bilateral theta burst stimulation: a randomized controlled pilot trial. Plewnia, C., Pasqualetti, P., Große, S., et al.[2018]

In a study involving 300 patients with treatment-resistant depression, accelerated bilateral theta burst stimulation (TBS) was found to be effective and safe, with a treatment response rate of 43.7% and a remission rate of 28.2%.

The study revealed no significant differences in efficacy between different TBS intensities or when compared to traditional unilateral 10 Hz rTMS, indicating that the accelerated TBS does not provide faster antidepressant effects.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Accelerated theta burst stimulation for the treatment of depression: A randomised controlled trial. Chen, L., Thomas, EHX., Kaewpijit, P., et al.[2022]

In a study of 50 patients with treatment-resistant depression (TRD), bilateral sequential theta-burst rTMS (bsTBS) demonstrated a 28% remission rate and a 52% response rate, indicating its potential effectiveness for patients who have not responded to other treatments.

The treatment was well tolerated, with only occasional mild adverse events reported, including muscle contractions and headaches, and a very low incidence of serious side effects, suggesting it is a safe option for managing TRD.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Bilateral sequential theta burst stimulation for multiple-therapy-resistant depression: A naturalistic observation study. Burhan, AM., Patience, JA., Teselink, JGP., et al.[2022]

In a randomized, double-blind trial involving 56 patients, intermittent theta burst stimulation (iTBS) over the dorsomedial prefrontal cortex showed a significant reduction in negative symptoms for patients with depression, but not for those with schizophrenia.

The treatment was generally safe and well-tolerated, with serious adverse events occurring only in the sham group, indicating that iTBS may be a promising intervention for depressive symptoms in certain patients.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression - a randomized controlled trial. Bodén, R., Bengtsson, J., Thörnblom, E., et al.[2021]

In a study of 27 participants, a prolonged intermittent theta burst stimulation (piTBS) protocol using 1,800 pulses showed limited effectiveness for major depressive disorder, with only 18.2% of participants achieving a response and 9.1% reaching remission.

Safety and tolerability were concerns, as 18.5% of participants experienced issues, suggesting that while piTBS is a promising approach, further research is needed to optimize its parameters and improve outcomes.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Prolonged intermittent theta burst stimulation in the treatment of major depressive disorder: a case series. Richard, M., Noiseux, C., Desbeaumes Jodoin, V., et al.[2022]

Theta-burst transcranial magnetic stimulation (TBS) is safe and well tolerated in patients with major depression, based on a study involving 33 participants over 10 consecutive days.

The study suggests that TBS may have antidepressant effects, and increasing stimulation parameters does not lead to more side effects, potentially enhancing its therapeutic benefits.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. Chistyakov, AV., Rubicsek, O., Kaplan, B., et al.[2019]

Repeated applications of Theta Burst stimulation (TBS) in rats showed complex effects on neuronal activity markers, with some markers increasing while others decreased, indicating that the response to TBS is not simply accumulative.

Specifically, while the expression of the vesicular glutamate transporter (VGLUT1) increased with stimulation, markers for inhibitory activity like GAD67 and calcium-binding proteins decreased, suggesting a nuanced interaction between excitatory and inhibitory neuronal responses to repeated TBS.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Dose-dependence of changes in cortical protein expression induced with repeated transcranial magnetic theta-burst stimulation in the rat. Volz, LJ., Benali, A., Mix, A., et al.[2016]

In a study involving 29 patients with major depression, continuous theta-burst transcranial magnetic stimulation (cTBS) did not show a significant overall improvement compared to sham treatment, indicating modest efficacy.

However, patients who were either medication-free or had unchanged medication status experienced a greater reduction in depression scores with active cTBS, suggesting it may be beneficial for those not responding to traditional pharmacological treatments.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Preliminary assessment of the therapeutic efficacy of continuous theta-burst magnetic stimulation (cTBS) in major depression: a double-blind sham-controlled study. Chistyakov, AV., Kreinin, B., Marmor, S., et al.[2018]

Citations

1.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11609094/

Theta burst stimulation for depression: a systematic review ...

The current study outcomes included the response rate (primary), depression symptom improvement, remission rate, all-cause discontinuation rate, ...

2.

pmc.ncbi.nlm.nih.gov

pmc.ncbi.nlm.nih.gov/articles/PMC11841443/

A meta-analysis comparing the effectiveness and safety of ...

Both rTMS and TBS are similarly effective in reducing depression and anxiety symptoms, with comparable side effect profiles.

3.

clinicaltrials.gov

clinicaltrials.gov/study/NCT07033780

NCT07033780 | Theta-Burst Stimulation to Treat Depression

The goal of this clinical trial is to explore the effects of non-invasive brain stimulation protocols using intermittent theta-burst stimulation (iTBS) on ...

4.

sciencedirect.com

sciencedirect.com/science/article/pii/S0165032723002604

Outcome of transcranial magnetic intermittent theta-burst ...

The aim of this study was to investigate the effectiveness and tolerability of iTBS for unipolar and bipolar depression in the clinical setting ...

5.

nature.com

nature.com/articles/s41591-023-02764-z

Connectivity-guided intermittent theta burst versus ... - Nature

Persistent decreases in depressive symptoms were seen over 26 weeks, with no differences between arms on the primary outcome GRID Hamilton ...

6.

nature.com

nature.com/articles/s41380-024-02630-5

Theta burst stimulation for depression: a systematic review ...

Theta burst stimulation (TBS) presents as a more efficient and potentially more effective therapeutic modality than conventional repetitive transcranial ...

7.

clinicaltrials.gov

clinicaltrials.gov/study/NCT07181226

High-Frequency vs. Theta-Burst TMS for Depression

Outcomes and Rationale The primary outcomes were changes in depressive symptoms measured by the Hamilton Depression Rating Scale (HAMD) and the ...

8.

sciencedirect.com

sciencedirect.com/science/article/abs/pii/S1094715923007420

Review Articles Efficacy and Safety of Theta Burst Versus ...

The aim of this meta-analysis was to compare TBS therapy with standard rTMS treatment regarding their safety and therapeutic effect on individuals with ...

9.

pubmed.ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov/36841303/

Outcome of transcranial magnetic intermittent theta-burst ...

In a clinical setting, iTBS was shown to be safe and tolerable and the response rate was similar to that reported from clinical trials.